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The Language of Life. DNA and the revolution in personalized 
medicine. Francis S. Collins  
New York etc.: Harper, 2011 
 
HUB ZWART1,2 
 
A lot has been written ... about the DNA revolution. But this book aims to be about the 
facts (Collins 2010, p.xxv) 
 
Francis Collins had an impressive track record as a gene hunter (cystic fibrosis, 
neurofibromatosis, Huntington’s disease) when he was appointed Director of the 
Human Genome Project (HGP) in 1993. In June 2000, together with Craig Venter and 
President Bill Clinton, he presented the draft version of the human genome sequence 
to a worldwide audience during a famous press conference. And in 2009, President 
Barack Obama nominated him as director of the National Institutes of Health (NIH), 
the largest Tfunding agency for biomedical research in the world. 
 
In 2006, Collins published his book The Language of God,3 an autobiographical 
account of the HGP and its scientific, historical, and societal significance, with special 
attention paid to the impact of the human sequence on the way we see our world and 
ourselves.4 Now, by way of a sequel, he has written The Language of Life. Whereas The 
Language of God focused on the genome sequence of mankind in general, and on the 
HGP as a “revolution” in biomedicine, the new book, as indicated by its subtitle, is 
oriented towards “the revolution in personalized medicine”, the impact of the 
genomics revolution on the personal lives of individuals. 
 
Before subjecting Collins’ book to a closer reading, I first of all would like to explain 
how I will read it and from what perspective. Why is genomics in general, and the 
HGP and its aftermath in particular, a subject of interest to a philosopher like me? 
Why did I become interested in assessing the HGP and in studying the work and 
views of some of its key contributors?    
Disruptive changes and the agenda of philosophy 
As my background is in continental philosophy, my research builds on the 
‘continental school’ within the philosophy of science. In this school, the French 
philosopher Michel Serres has played a decisive role, not least because of the 
significant impact his work has had on the views and methods of authors such as 
Foucault, Deleuze and Latour. In his book Hermes I, published in 1968 (the year of 
the May revolt), he argued that we live in an era of disruptive change, in science as 
well as in politics and other domains.5 Within the scientific realm, he claimed, the era 
of disruption is exemplified by the emergence of large-scale, high-tech, 
transdisciplinary research fields such as molecular biology. 
 
In Hermes I, Serres basically argued that philosophy had lost track of these 
developments and had become hopelessly outdated and irrelevant as a consequence. 
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In subsequent volumes of his Hermes series, however, a slightly more optimistic view 
is taken.6 Philosophy can be rescued and reanimated, Serres now argues, by taking an 
“empirical turn”. Philosophers can still play a pivotal role, provided that they acquaint 
themselves thoroughly with these newly emerging worlds of knowledge and research, 
from a position of close proximity. They must enter the capillaries and tissues of 
technoscience and really become embedded scholars. They must address the various 
philosophical issues raised by these developments in close interaction with the 
scientists involved. Thus, what Kant envisioned as an epistemology of pure reason 
should evolve into a kind of conceptual epidemiology, analysing and critically 
assessing the ways in which techniques, vocabularies, research practices and forms of 
information spread through research fields worldwide. Philosophers may then study, 
for instance, how in laboratories throughout the world, matter has given way to 
information as the key target of scientific inquiry. 
 
For Serres in the 1960s and 1970s, molecular biology was the place to be, the arena 
where the revolution manifested itself. For later generations of philosophers who are 
willing to following his lead, genomics has come to play a rather similar role during 
the past two decades or so. Genomics has widely been regarded as a true “revolution” 
in science7 and its main focus event, beyond doubt, was the June 2000 press 
conference mentioned above, where a draft version of the human sequence was 
presented to a group of prominent representatives of science and politics actually 
present, as well as to a global audience worldwide - Urbi et orbi, as it were. The 
sequence was presented as an important milestone for science as well as for humanity, 
and the focus was on the massive implications this achievement was to have for how 
biomedical research is conducted and medical health care is provided. Or, as Collins 
phrases it in his most recent book: “The HGP [is] considered by many to be one of the 
boldest scientific efforts that humankind has ever mounted.” (p.299) Indeed, one of 
the claims made during the conference was that “Our children’s children will know 
the word cancer only as a constellation of stars.” 
 
In 2010, the journal Nature published a retrospective. The basic question was: has the 
proclaimed genomics revolution arrived? Collins8  and Venter9 both contributed to the 
issue. Their answer and that of other contributors was, essentially: not yet. The most 
important outcome of the HGP resides in the acknowledgment that life is much more 
“complicated”10 than was envisioned back in 1989, when Francis Collins wrote his 
very first e-mail and the HGP was about to be launched. 
 
But this has not put an end to revolutionary science rhetoric - quite the contrary. The 
great expectations are still there. They are simply transferred from the general human 
sequence, deciphered by the HGP, to the coming of the personal genome. And that is, 
as I see it, a telling example of what Freud in The Interpretation of Dreams called 
“displacement” (“Verschiebung”).11 The enchanting dream scenarios are still very 
much alive, but they are transferred from the original object (the sequence of 
humankind as such) to the alluring substitutes (such as $1000 personal genome 
sequencing) that are currently emerging in the arena of personalised medicine and 
personalised genomics. In my view, Collins’ book is a rather symptomatic 
exemplification of this “displacement”, of this trend. The implication is not that these 
 
 
10           Genomics, Society and Policy 
             2010, Vol.6, No.3 pp.67-76 
 
_____________    
Genomics, Society and Policy, Vol.6, No.3 (2010) ISSN: 1746-5354 
© ESRC Genomics Network. www.gspjournal.com 
69
claims concerning the revolutionary nature of personalised medicine are false, or that 
they should be discarded right away as political tricks employed by research managers 
in their frantic search for novel streams of funding to keep their research communities 
alive. Rather, they provide us with a window into the concerns and desires that 
continue to fuel our contemporary will to know.12  
 
As I said, I regard Collins’ book as a “case study” of this phenomenon. In my review I 
will employ a specific way of reading for which the French philosopher Althusser 
coined the term “reading aloud”.13 The focus is on the discourse as such, and the floor 
first and foremost is given to the author himself. The tensions and crevices in his 
writings are bound to manifest themselves and become ‘audible’, and will be brought 
to the fore by reading carefully, by paying attention, not only to the content of the 
text, but also to the ‘sound’ of the language, the choice of words, the texture, the 
discursive ambiance as it were. Practically, it means that my reading will involve the 
use of quite a few quotations from the text. 
Reading aloud 
Chapter One of the book begins: 
 
Scientists aren’t generally prone to effusiveness. We are privately 
excited about our work, but in public we often, and rightly, 
emphasize skepticism and caution. But there are exceptional 
moments where skepticism is set aside, electricity fills the room, and 
a scientist with palpable passion and flashing eyes describes 
unabashedly a change in the landscape that will have lasting 
significance. Just a few months into the new millennium, I had that 
experience … After much anticipation, and many tumultuous 
moments, the achievement of an almost impossible audacious goal 
that had motivated all of us for a decade was now essentially 
assured. (p.1) 
 
This is not a reference to the June 2000  HGP press conference, but to a previous 
event: the “private, science-only version” (p.2) that took place in May 2000 at Cold 
Spring Harbor, “the Mecca where genome scientists made their pilgrimages every 
year” (p.2). The public announcement of the complete draft of the genome would 
follow one month later. This is how Collins “unabashedly” described the change in 
the landscape at that “science-only” ceremonial meeting:  
  
We have been engaged in a historic adventure. Whether your 
metaphor is Neil Armstrong or Lewis and Clark, your metaphor is at 
risk of falling short. There is no question that the enterprise we have 
gathered here to discuss will change our concepts of human biology, 
our approach to health and disease, and our view of ourselves. (p.2) 
 
And: 
 
With the sequencing of the entire genome, scientists could launch 
into a dizzying array of groundbreaking research projects to unlock 
the greatest secrets of the human body … We had climbed to the top 
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of the mountain, and we were about to start rushing down the other 
side, into a valley full of potential discoveries. (p.2) 
 
The core of the message is this: raising public expectations is not at all part of the 
daily business of science. It is only on very rare and exceptional occasions that the 
music of science is played in such a blazing key. Still, Collins is not disinclined to 
emphasise that he actually led what he describes as one of the boldest scientific efforts 
that humankind has ever mounted (p.299). 
 
What is left out of the picture thus painted is the pecuniary aspect of things. The 
expedition towards the genome summit required substantial funding, and with this in 
mind, the metaphor is slightly misleading. In Collins’ story it looks as if, after having 
received a significant amount of public investments - amounting to a $3 billion dollar 
grant - in order to pull them towards the top, the sciences can now be left to their own 
resources as they are now gliding down the slope. In fact, the human sequence was 
only the beginning. It is something like the first terrace of an extended and forbidding 
mountain range. Getting to the primary peak was a moment of high visibility for 
science. But now that the expedition has moved on beyond this first summit, 
researchers feel they are no longer within eyesight of their audiences. And this clearly 
is an issue of concern, because more funding will be needed for future stages:     
 
Nearly a decade has passed since that moment of celebration. 
Virtually all biomedical researchers would agree that their approach 
to understanding how life works has been profoundly and 
irreversibly affected by access to the complete DNA sequence of the 
human genome … But the effect on the public of all the hoopla in 
2000 has been mixed. Most people know that the genome has been 
spelled out, but they have lost track of what has happened since then. 
They remember the ascent of the mountain, but they are unaware of 
the rewards that are starting to appear in the valley. Some of the 
press announcements at the time implied an immediate 
transformation of medicine, but that was never realistic – lead times 
between basic discoveries in science and changes in practical 
medicine, technology, or daily life tend to be measured in decades. 
(p.3) 
 
In other words, the HGP has genuinely and dramatically affected science, but its 
implications for society seem hardly noticeable as yet. Partly due to the fact that mass 
media excessively amplified the ‘hoopla’ of the year 2000, the whole endeavour now 
threatens to go awry.14 That is a major threat because, on the slope at the opposite 
side, hardly noticeable to the public eye, the revolution is still raging. And that is what 
fuels the basic message of the book. The revolution is ongoing, and societies should 
still prepare themselves for a massive disruptive change, one that has taken more time 
to come about than expected perhaps, but is, nonetheless, still on its way:  
  
Healthy individuals are increasingly able to discover some of their 
body’s inner secrets and take appropriate action. The potential for 
individual prediction is beginning to spill out to the general public, 
offering the opportunity to take more control of your fate … None of 
this is happening overnight, and ultimate success will depend upon 
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the visionary investment of energy, talent, and financial resources by 
scientists, governments, universities, philanthropic foundations, 
biotechnology and pharmaceutical companies, and the general 
public. But without question, man’s knowledge of man is 
undergoing the greatest revolution since Leonardo. (p.5, my italics)  
 
This is an important quote because, more or less in passing, the financial dimension is 
finally being addressed. The revolution can only come about if governments and 
others continue to invest substantial “financial recourses” in the endeavour. In order 
for the genomics revolution to be really unleashed, funding is not a one-time injection, 
but a permanent necessity. I will now further illustrate Collins’ argument with the 
help of a few examples taken from his book  
A case of lumpectomy 
After being diagnosed with breast cancer, Karen (a pseudonym) underwent 
lumpectomy and the removal of 23 lymph nodes, Collins tells us. Tests for BRCA1 
and BRCA2 were negative. After radiation treatment, she was faced with the decision 
whether to proceed with chemotherapy, as recommended by three different 
oncologists. Then a family member informed her about a gene expression analysis to 
test the tumour’s likely aggressiveness. On the basis of this test, she decided to skip 
chemotherapy and to pursue hormonal therapy alone. “This”, according to Collins, 
“represents one of the first fruits of the genomics revolution, and Karen is one of its 
pioneers” (p.4). Her case: 
 
exemplifies a new approach to medicine that will affect virtually all 
facets of health care ... many accepted principles of medicine and 
biology require substantial revision ... Healthy individuals are 
increasingly able to discover some of their body’s inner secrets and 
take appropriate actions. (p.5) 
 
No one will deny, I gather, that in this case the opportunity provided by genetic 
testing to forego chemotherapy was highly beneficial to the patient involved. And yet, 
something more must be expected when it comes to presenting evidence for the claim 
that we are witnessing a breathtaking revolution that changes medicine, biology and 
human life. During the past two centuries, medicine has been experiencing progress 
and innovation more or less continuously. What Collins describes is basically the 
availability (in certain cases) of an additional source of information that may enhance 
the quality of decision-making in therapy settings. But events like that, I would argue, 
happen all the time, as more tools for diagnosis and treatment are being developed 
quite regularly. It represents an improvement, surely, but not a quantum leap. Taken 
in isolation, the case does not prove that much. What about a slightly different case, 
for instance, where a gene test will encourage rather than discourage chemotherapy, 
or where genome information (usually expressed in terms of probabilities and risks) 
will make a difficult decision even more bewildering, due to statistical information 
overload? For a revolution to be real, one would expect completely new horizons and 
vistas to be opened up. But, of course, Collins’ book contains examples of this as 
well. They notably emerge whenever genomics becomes closely interwoven with 
other high profile areas of inquiry, such as brain research and stem cell research.  
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Brain genomics 
Collins grew up on a farm inTT Shenandoah Valley, Virginia, where his father was a 
collector of American folk songs, and for Collins the story of brain genomics begins 
with folk musician Woody Guthrie who died at 55 from a highly inheritable 
neurodegenerative illness, Huntington’s disease. But this is a classical monogenetic 
affliction. What added value can personalised genomics offer?  
 
Of all the organs in the body, Collins argues, “the brain is the one where 
environmental interactions are most crucial” (p.187). External stimulation during 
childhood is essential for brain development, and throughout life the experience of 
learning results in changes in neuronal connections, while these same neuronal 
connections can be more or less irreversibly disrupted by illness or drugs (p.187). 
Still, brain functioning involves a tremendous amount of input from our 20,000 or so 
protein-coding genes.  
 
One of the examples Collins uses to herald the new era of brain genomics is alcohol 
dependence. As Collins explains, we now understand that alcohol, after producing its 
immediate mental effect, is converted by enzymes to acetaldehyde, a toxic substance, 
and finally to acetate, an energy source. Some individuals, according  to their genetic 
disposition, have a slow-acting first enzyme and a fast-working second enzyme. For 
them, alcohol intoxication is a pleasurable experience for quite an extended period of 
time, before the untoward effects of acetaldehyde become noticeable. They are likely 
to be more prone to alcohol abuse. In others, the effects of acetaldehyde become 
noticeable quite soon, because the first enzyme acts faster and the second one slower, 
and therefore, they tend not to like alcohol that much. 
 
Once again, although it may be enlightening to understand the biochemistry of the 
process in more detail, this in itself does not constitute sufficient evidence for 
convincingly making the case that we are experiencing a remarkably high tide of 
revolutionary changes and horizon expansions. Individual differences in enjoying 
alcohol use are already common knowledge, I would say, and each of us will probably 
know from experience into which of the two categories described above he or she is 
most likely to fall, without the need for genetic testing. Will knowledge concerning 
the genes involved really affect the management of our daily lives? 
 
Another example given by Collins is the impact of the personalised genomics 
revolution on assessing personality traits. Currently, personality tests such as the 
Myers-Briggs test are quite commonly used, notably in human resources management 
(assessing the personality traits of job applicants and employees). In recent years, a 
number of genes associated with personality traits have entered the stage. As Collins 
makes clear, four of these seemed to be strongly inherited: genes associated with 
novelty seeking, harm avoidance, reward dependence and persistence. A gene called 
DRD4, for instance, involved in dopamine metabolism, has been baptised the novelty-
seeking gene. As Collins himself points out, however, follow-up studies have failed to 
confirm the initial claims. And although some genes may contribute to these 
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personality traits, each of the many genes involved will contribute a very small effect, 
so that “claims of predictability of personality traits based on DNA testing should be 
taken with considerable skepticism” (p.200). The same holds for the genetic basis of 
another personality trait, “infidelity”. Given that bonding behaviour differs so widely 
among various species of mammals and birds (ranging from faithful species of swans 
who display monogamous bonding to chimpanzees, who are notoriously 
promiscuous), a genetic component may be involved. But again, although companies 
offer genetic fidelity tests on the web, Collins himself advocates scepticism in this 
matter:  
 
“Do not be misled … the actual influence on the behaviour on an individual 
male [of the gene in question] is quite modest, and should certainly not be 
used in mate selection or as an excuse for cheating one’s partner” (204).  
 
For indeed:  
 
“a full understanding of the way the brain functions … is still a distant goal for 
science … Our human brains may simply not be sufficiently complex to 
understand themselves” (p.207).  
 
In short, given the multitude of relatively weak genetic factors, DNA analysis will be 
of limited utility when it comes to assessing personality traits (p.208). At the same 
time Collins continues to opine that brain genomics will have revolutionary effects, 
albeit predominantly in the treatment of psychiatric disorders:  “genetic factors 
predisposing to the major mental disorders will emerge in the next few years” (p.207). 
For such disorders we can “anticipate significant advances … in the near future” 
(p.207).  
 
In other words, we are faced with a sequence of claims that seem difficult to combine. 
Claim 1 asserts that we are in the middle of a revolution that will change science, 
medicine and human life. Claim 2 asserts that, up to now, concrete instances of 
progress are actually quite modest, due to the astounding complexity of genomes, 
brains, and other items on the list of biological research. Claim 3 insists nonetheless 
that important breakthroughs (albeit difficult to specify as yet) will most certainly 
come about in the near future.   
Genomics and the iPS Cell revolution 
The same pattern emerges where Collins addresses the genomics research agenda in 
the context of current developments in stem cell research aimed at developing 
therapies for degenerative diseases. In Collins’ view, given the persistent constraints 
on and drawbacks of gene therapy as well as whole organ transplantation, stem cell 
therapy has the potential to provide the optimal solution. For indeed, “If delivery of 
genes to cells is potentially beneficial but technically challenging, why not just deliver 
the cells?” (p.260). As Collins argues, our ability “to reprogram human cells has 
opened up an entirely new vista of potential therapeutics” (261). This builds up to the 
conclusion once again that a revolution is in the making.  
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“Only a few times in my career have I witnessed a scientific 
development that qualifies as a true revolution” (p.266) 
 
But our ability to transform a cell into a stem cell in the laboratory (i.e. the production 
induced pluripotent stem cells - iPS cells) was such a moment:  
 
“It opens up a new window for research and potential clinical 
applications” (266).  
 
Utterances of this type reside under the heading of what I referred to as Claim 1. They 
proclaim and outline a revolution in the making. Yet, again, this set of utterances is 
immediately followed by Claim 2- and then Claim 3-type utterances: 
 
“The therapeutic use of iPS cells is still very uncertain... (p.266) 
[Claim 2] 
 
In fact: 
 
“before we get too carried away about the potential of iPS cells to 
cure a long list of degenerative diseases, it should be mentioned that 
there are serious existing concerns about whether such cells might 
be, shall we say, a bit too exuberant in their potential, actually 
causing tumours in the person receiving them … I will be several 
years before the potential of iPS cells for therapeutics can be 
determined, but it is entirely possible that this approach will find 
clinical application” (267) [Claim 2]. 
 
Nonetheless, it is argued that the development of iPS cells “holds great promise” 
(p.167) [Claim 3]. To this, Collins adds what he refers to as the first law of 
technology: “The consequences of a radical new technology are almost always 
overestimated in the short term and underestimated in the long term” (p.268).  
 
So, again, we are confronted with a script consisting of three components. First, we 
are told that we are witnessing a revolution (a “disruptive innovation”, p.275). 
Second, it is made clear that concrete results so far are contentious and far from 
revolutionary in themselves. Yet third, it is maintained that it is undeniable that we are 
about to enter a completely new landscape. 
Will the revolution arrive? 
The vital question, then, is what is needed in order to turn these highly uncertain 
prospects into a really revolutionary change, into a “disruptive innovation”? The 
answer is given quite explicitly: 
 
“We live in an exciting time in medical research, where a series of 
‘disruptive innovations’ promise to revolutionize diagnosis, 
prevention and treatment. But this revolution will sputter out if we do 
not make continued major investments in the research needed to 
explore these new approaches. Worldwide, medical research is 
seriously underfunded in nearly all countries...” (p.275, my italics). 
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In other words, in order to make it all happen, in order to cross the valleys of 
uncertainty between ‘terrace one’ and the subsequent peaks, this type of research will 
be in need of sustained massive funding, as scientists continue their ascent towards an 
ever-retreating summit, a final peak still shrouded in mist, in a mountain range of 
ever-increasing complexity.  
 
And this reveals a (potentially fatal) flaw or weakness in the narrative. The human 
sequence – the first terrace in the mountain landscape – provided a clear focus, a 
challenging target, something with which politicians and others could identify. 
Beyond this peak, this vision is bound to become blurred, with multiple targets arising 
and the distances between the research teams climbing through this landscape and 
their audiences at the foot of the mountains continually increasing. All these factors, 
in combination with financial crises, global competition, and other form of societal 
turbulence, will make it increasingly difficult to convince governments to continue to 
invest in complex research that may become disruptive in the future. In other words, 
with this book, Francis Collins once again assumes the role of spokesperson for a 
major campaign to reach “an almost impossible audacious goal”: ascertaining novel 
funding streams for “big biology” whose results so far, from a societal perspective at 
least, are fairly disappointing. The claim that the $ 1,000 genome will “enable a 
personalized plan of preventive medicine to be established” is not supported by the 
evidence as presented. 
 
Collins’ book is fairly disappointing in other respects as well. I take it as rather 
symptomatic for the approach adopted by the author that, instead of using the June 
2000 press conference as his point of departure, as is done in previous publications, 
Collins now prefers the “science-only” celebration that took place one month earlier. 
This is symptomatic of the fact that the book conveys a “science-only”, technology-
driven vision of future developments. The various pitfalls and concerns involved in 
personalised medicine and human genome sequencing are more or less delisted from 
the agenda, in order to clear the way, as it were, for the potential benefits as 
envisioned from the point of view of pure science. From a bioethical and societal 
perspective, the book represents a remarkable relapse into a science-only, pre-HGP 
approach to science. It is as if the many fruitful collaborations between genomics 
researchers and experts from social sciences and the humanities, in order to analyse 
and assess the societal implications of genomics, did not yield any noticeable results. 
This is disappointing, especially because, in previous books and papers published by 
this highly influential author, a much more interdisciplinary approach was taken, and 
social, ethical and philosophical issues were taken on board. Indeed, as a director of 
the HGP, Collins was responsible for the ELSI programme as well. While the 
complexities of living systems are finally recognised, the complexities involved in the 
societal embedding of genomics (in health care and other areas) are suddenly 
underestimated in a rather disquieting way. I do not consider this a very promising 
course to take.          
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